Low; Walter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Low; Walter.The latest application filed is for "compositions for the prevention and treatment of parkinson's disease".

Company Profile

3.7.20

Low; Walter - Shorewood MN
Low; Walter - Minneapolis MN
Low; Walter - Saint Paul MN US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions For The Prevention And Treatment Of Parkinson's Disease App 20220267367 - Low; Walter ; et al.	2022-08-25
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20210346473 - McIvor; R. Scott ; et al.	2021-11-11
Compositions For The Prevention And Treatment Of Parkinson's Disease App 20210122780 - Low; Walter ; et al.	2021-04-29
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20210085760 - McIvor; R. Scott ; et al.	2021-03-25
Methods To Treat Pompe Disease Using A Recombinant Adeno-associated Virus App 20210085759 - McIvor; R. Scott ; et al.	2021-03-25
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20190298812 - McIvor; R. Scott ; et al.	2019-10-03
Deuterated bile acids Grant 10,144,758 - Finch , et al. De	2018-12-04
Methods To Treat Pompe Disease Using A Recombinant Adeno-associated Virus App 20180271956 - McIvor; R. Scott ; et al.	2018-09-27
Methods To Treat Ceroid Lipofuscinosis Using A Recombinant Adeno-associated Virus App 20180271957 - McIvor; R. Scott ; et al.	2018-09-27
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20180271955 - McIvor; R. Scott ; et al.	2018-09-27
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20180264090 - McIvor; R. Scott ; et al.	2018-09-20
Methods To Treat Mucopolysaccharide Type Ii Or Deficiency In Iduronate-2-sulfatase Using A Recombinant Adeno-associated Virus Encoding Iduronate-2-sulfatase App 20180099030 - McIvor; R. Scott ; et al.	2018-04-12
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20180036388 - McIvor; R. Scott ; et al.	2018-02-08
Deuterated Bile Acids App 20180030084 - Finch; Michael D. ; et al.	2018-02-01
Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase Grant 9,827,295 - McIvor , et al. November 28, 2	2017-11-28
Deuterated bile acids Grant 9,708,362 - Finch , et al. July 18, 2	2017-07-18
Therapeutic composition for treatment of glioblastoma Grant 9,662,377 - Olin , et al. May 30, 2	2017-05-30
Therapeutic Composition For Treatment Of Glioblastoma App 20160263207 - Olin; Michael Raymond ; et al.	2016-09-15
Deuterated Bile Acids App 20160168189 - Finch; Michael D. ; et al.	2016-06-16
Therapeutic composition for treatment of glioblastoma Grant 9,364,505 - Olin , et al. June 14, 2	2016-06-14
Adeno-associated Virus Mediated Gene Transfer To The Central Nervous System App 20160120960 - McIvor; R. Scott ; et al.	2016-05-05
Deuterated Bile Acids App 20150112089 - Finch; Michael D. ; et al.	2015-04-23
Therapeutic Composition For Treatment Of Glioblastoma App 20130323300 - Olin; Michael Raymond ; et al.	2013-12-05
Use of umbilical cord blood stem cells to treat ischemic event Grant 8,309,070 - Low , et al. November 13, 2	2012-11-13
Use of umbilical cord blood stem cells to treat ischemic event App 20070172465 - Low; Walter ; et al.	2007-07-26
Anionic liposomes for delivery of bioactive agents App 20030026831 - Lakkaraju, Aparna ; et al.	2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.